p21 Protein Expression in Breast Cancer
Author Information
Author(s): M Barbareschi, Caffo, C Doglioni, P Fina, A Marchetti, F Buttitta, R Leek, L Morelli, E Leonardi, G Bevilacqua, P Dalla Palma, AL Harris
Primary Institution: S. Chiara Hospital, Trento, Italy
Hypothesis
How does p21 expression correlate with clinicopathological data and relapse-free survival in breast carcinoma?
Conclusion
High p21 expression is associated with short relapse-free survival in breast cancer patients.
Supporting Evidence
- High p21 expression was seen in 24 (26%) cases, associated with high tumour grade.
- p21 expression in cases with p53 gene mutations was low in six cases and high in one.
- Statistical analysis showed a significant relationship between high p21 expression and short relapse-free survival.
Takeaway
This study looked at a protein called p21 in breast cancer and found that when there's a lot of it, patients tend to have shorter times without cancer returning.
Methodology
The study involved immunohistochemical analysis of p21 expression in 91 breast carcinoma samples, with follow-up data collected over a median of 58 months.
Limitations
The small and heterogeneous number of cases may bias the survival analysis.
Participant Demographics
Patients included 57 node-negative and 34 node-positive breast carcinoma cases.
Statistical Information
P-Value
0.003
Statistical Significance
p=0.003
Want to read the original?
Access the complete publication on the publisher's website